![Brigette Roberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brigette Roberts
Direktor/Vorstandsmitglied bei
QUINCE THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2026
Profil
Brigette Michelle Roberts is the founder of YYC Capital Management LLC, founded in 2009.
Dr. Roberts is currently Chief Executive Officer & Director at OrphAI Therapeutics, Inc. since 2021.
Dr. Roberts is also Director & Chief Corporate Affairs Officer at Quince Therapeutics, Inc. starting in 2026.
Former positions include Director at Ligand Pharmaceuticals, Inc. from 2005 to 2007, Principal at Third Point Management Co. LLC from 2005 to 2008, Associate at Thomas Weisel Partners LLC from 2001 to 2002, Principal at Nomura Securities International, Inc. in 2012, and Principal at Sturzas Institutional Research, Inc. in 2003.
Education includes an undergraduate degree from Harvard University in 1995 and a doctorate from New York University in 1999.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.05.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Brigette Roberts
| Unternehmen | Position | Beginn |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 18.05.2026 |
AI Therapeutics, Inc.
 AI Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Brigette Roberts
| Unternehmen | Position | Ende |
|---|---|---|
Nomura Securities International, Inc.
 Nomura Securities International, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.12.2012 |
YYC Capital Management LLC
 YYC Capital Management LLC Investment ManagersFinance YYC Capital Management manages a long/short equity hedge fund | Gründer | 01.01.2012 |
Third Point Management Co. LLC
 Third Point Management Co. LLC Investment ManagersFinance Third Point Management Co. employs an event driven, value-oriented investment approach. Though not limited by sector, the firm tends to invest in the stocks of companies in the energy minerals, industrial services, finance and electronic technology sectors. They invest across all market-caps with most of their investments made in companies located in the US, Europe and Latin America. Third Point Management's research is based on a combination of bottom-up and top-down analysis that seeks to identify undervalued stocks. | Portfolio Manager-Aktien | - |
| LIGAND PHARMACEUTICALS INCORPORATED | Direktor/Vorstandsmitglied | 01.03.2007 |
Sturzas Institutional Research, Inc.
 Sturzas Institutional Research, Inc. Investment Banks/BrokersFinance Provides investment research | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Brigette Roberts
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Third Point Management Co. LLC
Third Point Management Co. LLC Investment ManagersFinance Third Point Management Co. employs an event driven, value-oriented investment approach. Though not limited by sector, the firm tends to invest in the stocks of companies in the energy minerals, industrial services, finance and electronic technology sectors. They invest across all market-caps with most of their investments made in companies located in the US, Europe and Latin America. Third Point Management's research is based on a combination of bottom-up and top-down analysis that seeks to identify undervalued stocks. | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Nomura Securities International, Inc.
Nomura Securities International, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sturzas Institutional Research, Inc.
Sturzas Institutional Research, Inc. Investment Banks/BrokersFinance Provides investment research | Finance |
YYC Capital Management LLC
YYC Capital Management LLC Investment ManagersFinance YYC Capital Management manages a long/short equity hedge fund | Finance |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
AI Therapeutics, Inc.
AI Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
